We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





UV Disinfection Robot Neutralizes Coronavirus and Protects Patients and Healthcare Workers from COVID-19

By HospiMedica International staff writers
Posted on 21 Dec 2020
UV disinfection robots are being increasingly deployed across hospitals around the world to combat the novel coronavirus and further protect patients and healthcare workers from COVID-19.

UV disinfection company Surfacide’s (Waukesha, WI, USA) Helios System of UV robots are designed to help protect and keep patients and healthcare workers safe. More...
Surfacide's UV-C technology is scientifically proven to inactivate coronavirus - the family of viruses that make up SARS-CoV-2 and COVID-19. Surfacide is the world's first and only patented, automated, multiple-emitter UV-C system to safely eradicate harmful bacteria and viruses from environments. Surfacide’s Helios System uses multiple UV-C light towers simultaneously to rapidly eliminate and prevent the spread of dangerous microorganisms, including Coronavirus, SARS-CoV-2, C.diff, MRSA, VRE, CRE and Acinetobacter. Surfacide UV-C is scientifically proven to rapidly decontaminate SARS-CoV-2 (COVID-19) colonized surfaces, reducing virus and bacteria in a single cycle in as little as five minutes.

"We are grateful that so many pediatric hospitals have adopted Surfacide's powerful, trusted UV-C robot technology during these critical times," said Gunner Lyslo, Founder and CEO of Surfacide. "We are proud that Surfacide UV-C is having a positive impact in combating COVID-19 and protecting our most vulnerable young patients and all of the frontline essential healthcare workers that care for them."

Related Links:
Surfacide


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.